Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Genome interpreter vies for place in clinical market

Nature volume 490, page 157 (2012)Cite this article

Subjects

Launch of system that keeps data local aims to address privacy fears.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Monya Baker
    View author publications

    You can also search for this author inPubMed Google Scholar

Additional information

See Editorial, p. 143.

Related links

Related links

Related links in Nature Research

Rapid test pinpoints newborns' genetic diseases in days 2012-Oct-03

Human genetics: Genomes on prescription 2011-Oct-05

Genome giant offers data service 2011-Jul-26

Next-generation sequencing: adjusting to data overload 2010-Jul-01

Give me my genome 2008-Oct-21

Blogpost: DNA has limits, but so does study questioning its value, geneticists say

Blogpost: 2011: the year when whole genome sequencing becomes blasé?

Related external links

George Church

Knome knoSYS 100 Overview

David Goldstein

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baker, M. Genome interpreter vies for place in clinical market. Nature 490, 157 (2012). https://doi.org/10.1038/490157a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/490157a

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research